Literature DB >> 26456151

Chronic inflammatory autoimmune disorders are a risk factor for red blood cell alloimmunization.

Alex B Ryder1, Jeanne E Hendrickson1,2, Christopher A Tormey3,4.   

Abstract

Entities:  

Keywords:  RBC alloantibodies; RBC alloimmunization; blood group antigens; chronic inflammatory disorders; inflammation

Mesh：

Substances：

Year:  2015        PMID： 26456151      PMCID： PMC7025713          DOI： 10.1111/bjh.13781

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Routine non-ABO blood group antigen genotyping in sickle cell disease: the new frontier in pretransfusion testing?

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2015-06       Impact factor: 3.157

2.  Red blood cell alloimmunization is influenced by recipient inflammatory state at time of transfusion in patients with sickle cell disease.

Authors:  Ross M Fasano; Garrett S Booth; Megan Miles; Liping Du; Tatsuki Koyama; Emily Riehm Meier; Naomi L C Luban
Journal:  Br J Haematol       Date:  2014-09-26       Impact factor: 6.998

3.  Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells.

Authors:  Jeanne E Hendrickson; Maxime Desmarets; Seema S Deshpande; Traci E Chadwick; Christopher D Hillyer; John D Roback; James C Zimring
Journal:  Transfusion       Date:  2006-09       Impact factor: 3.157

4.  Alloimmunization in sickle cell disease: changing antibody specificities and association with chronic pain and decreased survival.

Authors:  Marilyn J Telen; Araba Afenyi-Annan; Melanie E Garrett; Martha R Combs; Eugene P Orringer; Allison E Ashley-Koch
Journal:  Transfusion       Date:  2014-12-01       Impact factor: 3.157

Review 5.  The Influence of Clinical and Biological Factors on Transfusion-Associated Non-ABO Antigen Alloimmunization: Responders, Hyper-Responders, and Non-Responders.

Authors:  Eric A Gehrie; Christopher A Tormey
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747

6.  Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans.

Authors:  Christopher A Tormey; John Fisk; Gary Stack
Journal:  Transfusion       Date:  2008-07-09       Impact factor: 3.157

7.  High risk of transfusion-induced alloimmunization of patients with inflammatory bowel disease.

Authors:  Pavol Papay; Klaus Hackner; Harald Vogelsang; Gottfried Novacek; Christian Primas; Walter Reinisch; Alexander Eser; Andrea Mikulits; Wolfgang R Mayr; Günther F Körmöczi
Journal:  Am J Med       Date:  2012-05-04       Impact factor: 4.965

8.  Multiple or uncommon red cell alloantibodies in women: association with autoimmune disease.

Authors:  G Ramsey; S J Smietana
Journal:  Transfusion       Date:  1995-07       Impact factor: 3.157

9.  Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization?

Authors:  Mark H Yazer; Darrell J Triulzi; Beth Shaz; Teresa Kraus; James C Zimring
Journal:  Transfusion       Date:  2009-02-27       Impact factor: 3.157

Review 10.  Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models.

Authors:  Alex B Ryder; James C Zimring; Jeanne E Hendrickson
Journal:  Transfus Med Hemother       Date:  2014-11-17       Impact factor: 3.747
  10 in total
  19 in total

Review 1.  Transfusion-related red blood cell alloantibodies: induction and consequences.

Authors:  Christopher A Tormey; Jeanne E Hendrickson
Journal:  Blood       Date:  2019-02-26       Impact factor: 22.113

2.  The impact of vaccination on RBC alloimmunization in a murine model.

Authors:  P Natarajan; M Santhanakrishnan; C A Tormey; J E Hendrickson
Journal:  Vox Sang       Date:  2017-06-08       Impact factor: 2.144

Review 3.  Cellular immune responses in red blood cell alloimmunization.

Authors:  James C Zimring; Krystalyn E Hudson
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02

4.  Impact of azacitidine on red blood cell alloimmunisation in myelodysplastic syndrome.

Authors:  Sebastián Ortiz; Maria T Orero; Karla Javier; Carolina Villegas; Irene Luna; Pedro Pérez; Mónica Roig; María López; Sofía Costa; Félix Carbonell; Rosa Collado; David Ivars; Mariano Linares
Journal:  Blood Transfus       Date:  2016-06-24       Impact factor: 3.443

5.  Recipient priming to one RBC alloantigen directly enhances subsequent alloimmunization in mice.

Authors:  Seema R Patel; Ashley Bennett; Kathryn Girard-Pierce; Cheryl L Maier; Satheesh Chonat; Connie M Arthur; Patricia E Zerra; Amanda Mener; Sean R Stowell
Journal:  Blood Adv       Date:  2018-01-23

6.  B cells require Type 1 interferon to produce alloantibodies to transfused KEL-expressing red blood cells in mice.

Authors:  David R Gibb; Jingchun Liu; Manjula Santhanakrishnan; Prabitha Natarajan; David J Madrid; Seema Patel; Stephanie C Eisenbarth; Christopher A Tormey; Sean R Stowell; Akiko Iwasaki; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2017-08-23       Impact factor: 3.157

7.  Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease.

Authors:  Raisa Balbuena-Merle; Susanna A Curtis; Lesley Devine; David R Gibb; Matthew S Karafin; Chance John Luckey; Christopher A Tormey; Alexa J Siddon; John D Roberts; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2019-07-29       Impact factor: 3.157

8.  Type 1 IFN signaling critically regulates influenza-induced alloimmunization to transfused KEL RBCs in a murine model.

Authors:  Dong Liu; David R Gibb; Vicente Escamilla-Rivera; Jingchun Liu; Manjula Santhanakrishnan; Zhimin Shi; Lan Xu; Stephanie C Eisenbarth; Jeanne E Hendrickson
Journal:  Transfusion       Date:  2019-08-12       Impact factor: 3.157

9.  Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database.

Authors:  Matthew S Karafin; Matt Westlake; Ronald G Hauser; Christopher A Tormey; Philip J Norris; Nareg H Roubinian; Yanyun Wu; Darrell J Triulzi; Steve Kleinman; Jeanne E Hendrickson
Journal:  Br J Haematol       Date:  2018-04-19       Impact factor: 6.998

Review 10.  Understanding red blood cell alloimmunization triggers.

Authors:  Jeanne E Hendrickson; Christopher A Tormey
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2016-12-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.